FDA shares additional draft guidance on CGTs
The FDA has released a draft of new guidance addressing common FAQs about the development of potential CGT treatments.
Social Responsibility
Zentiva voices UWWTD concerns as EU grants approval
UPFs fuelling ‘alarming rise of chronic diseases’ in india
Global conflicts prompt GPEI to delay polio eradication target
Advancing Pharmaceutical Security: The Role of SECURtracers in On-Dose Authentication
Social media algorithms are driving the GLP-1 drugs boom
As mpox spreads, ‘national governments have a moral responsibility to help’
Combating Pharmaceutical Crime with On-Dose Authentication
